[The role of hyperbaric oxygenation in combined treatment of acute pyelonephritis] | Canada Hyperbarics Skip to main content
Study Urologiia 2010

[The role of hyperbaric oxygenation in combined treatment of acute pyelonephritis]

Sokolova K — Urologiia, 2010

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated hyperbaric oxygen therapy as part of the combined treatment for 66 patients with acute pyelonephritis and in an experiment on 40 rats.

What They Found

The study found that using HBOT (8-10 sessions at 2.0-2.4 ATA for 60 minutes) reduced the need for surgery by 36.2% and shortened hospital stays by 16.9% for patients with acute pyelonephritis. HBOT also lessened systemic inflammation by 1.62 times and polyorganic insufficiency by 2.9 times, improved kidney function, and boosted immune recovery. In rats, HBOT decreased inflammation in kidney tissue.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study is a single-center investigation from 2010, which may limit the generalizability of its findings.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 21254635
Year Published 2010
Journal Urologiia
MeSH Terms Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Female; Glomerular Filtration Rate; Humans; Hyperbaric Oxygenation; Inflammation; Kidney; Male; Middle Aged; Pyelonephritis; Rats

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.